Professor Douglas Goodwin and Professor Angela Calderon of Pharmacal Sciences have received funding for their Internal Grant Proposal, “Toward new antitubercular drugs: Uncovering mechanistically appropriate inhibitors of Mycobacterium tuberculosis shikimate kinase from natural products”.
